Hasil Filter

12560

Total database: 17430
Struktur (SMILES)
9109 (72.5%)
Target
6912 (55.0%)
Genomik
109 (0.9%)
Referensi
12560 (100.0%)

Tipe Molekul

Distribusi Wujud Zat

Status Regulasi

Hasil Pencarian (12560)

Halaman 242 / 252
Valinomycin DB14057
small molecule | CAS: 2001-95-8

A cyclododecadepsipeptide ionophore antibiotic produced by Streptomyces fulvissimus and related to the enniatins. It is composed of 3 moles each of L-valine, D-alpha-hydroxyisovaleric acid, D-valine, and L-lactic acid linked alternately to form a 36-membered …

Kategori:
Amino Acids, Peptides, and ProteinsAnti-Bacterial AgentsAnti-Infective Agents +9
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Valnoctamide DB13099
small molecule | CAS: 4171-13-5

Valnoctamide has been used in trials studying the treatment of Mania and Schizoaffective Disorder, Manic Type.

Kategori:
Central Nervous System DepressantsHypnotics and SedativesNervous System +1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Valoctocogene roxaparvovec Approved DB15561
biotech | CAS: 1819334-78-5

Valoctocogene roxaparvovec is an adeno-associated virus serotype 5 (AAV5) based gene therapy vector that expresses the B-domain deleted SQ form of human coagulation factor VIII (hFVIII-SQ).[L43282] The expression of hFVIII-SQ is driven by a liver-specific pro…

Kategori:
Adeno-associated Viral Vector TherapiesAmino Acids, Peptides, and ProteinsBiological Factors +9
Target Protein:
Coagulation factor VIII (F8)
Waktu Paruh-
Vol. Distribusi-
KlirensThe maximum time to…
Genetik -
Valomaciclovir DB06575
small molecule | CAS: 195157-34-7

Deskripsi belum tersedia.

Kategori:
Antiviral AgentsHerpes ZosterHeterocyclic Compounds, Fused-Ring +4
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule | CAS: 195156-77-5

Valomaciclovir stearate is under investigation in clinical trial NCT00831103 (A Phase 2b Trial of EPB-348 for the Treatment of Herpes Zoster).

Kategori:
Antiviral AgentsHerpes ZosterHeterocyclic Compounds, Fused-Ring +4
Target Protein:
DNA polymerase catalytic subunit
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Valopicitabine DB13920
small molecule | CAS: 640281-90-9

The 3-O-valine ester prodrug of the nucleoside analog 2'-C-methylcytidine with anti-hepatitis C virus (HCV) activity. Upon administration, valopicitabine is converted into 2'-C-methylcytidine; upon phosphorylation into its 5-triphosphate form, this metabolite…

Kategori:
Nucleic Acids, Nucleotides, and NucleosidesNucleosidesPyrimidines
Target Protein:
Genome polyprotein
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Valproate bismuth Approved DB13910
small molecule | CAS: 60364-28-5

Valproate bismuth is available in Canada in the over-the-counter medication Neo-Laryngobis.

Kategori:
Bismuth containing drugsEENT Drugs, MiscellaneousNeurotoxic agents +1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Valproic acid Approved DB00313
small molecule | CAS: 99-66-1

Valproic acid, or valproate, is an fatty acid derivative and anticonvulsant originally synthesized in 1881 by Beverly S. Burton.[A178051] It enjoyed use as a popular organic solvent in industry and pharmaceutical manufacturing for nearly a century. In 1963, a…

Kategori:
Acids, AcyclicAnti-epileptic AgentAnticonvulsants +68
Target Protein:
4-aminobutyrate aminotransferase, mitochondrialGlycogen synthase kinase-3 alphaHistone deacetylase 9 +13
Gen Terkait:
POLG POLG
Waktu Paruh13-19 hours.[label]…
Vol. Distribusi11 L/1.73m<sup>2</s…
Klirens0.56 L/hr/m<sup>2</…
Genetik 2 Varian
Valpromide DB04165
small molecule

Deskripsi belum tersedia.

Kategori:
Acids, AcyclicAnticonvulsantsCentral Nervous System Agents +8
Target Protein:
Limonene-1,2-epoxide hydrolase
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Valrocemide DB06657
small molecule | CAS: 92262-58-3

Deskripsi belum tersedia.

Kategori:
Amino AcidsAmino Acids, Peptides, and Proteins
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Valrubicin Approved DB00385
small molecule | CAS: 56124-62-0

Valrubicin (N-trifluoroacetyladriamycin-14-valerate) is a chemotherapy drug commonly marketed under the trade name VALSTAR. It is a semisynthetic analog of the [doxorubicin], which is an anthracycline drug. Used in the treatment of the bladder cancer, valrub…

Kategori:
Anthracycline Topoisomerase InhibitorAnthracyclinesAnthracyclines and Related Substances +9
Target Protein:
DNADNA topoisomerase 2-betaDNA topoisomerase 2-alpha
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Valsartan Approved DB00177
small molecule | CAS: 137862-53-4

Valsartan belongs to the angiotensin II receptor blocker (ARB) family of drugs, which also includes [telmisartan], [candesartan], [losartan], [olmesartan], and [irbesartan]. ARBs selectively bind to angiotensin receptor 1 (AT1) and prevent the protein angiote…

Kategori:
Agents Acting on the Renin-Angiotensin SystemAgents causing angioedemaAgents causing hyperkalemia +22
Target Protein:
Type-1 angiotensin II receptor
Waktu ParuhAfter intravenous (…
Vol. DistribusiThe steady-state vo…
KlirensFollowing intraveno…
Genetik -
Valspodar DB11869
small molecule | CAS: 121584-18-7

Valspodar has been used in trials studying the treatment of Cancer, Sarcoma, Leukemia, Lymphoma, and Breast Cancer, among others.

Kategori:
Amino Acids, Peptides, and ProteinsATP Binding Cassette Transporter, Subfamily B, Member 1Drug Resistance, Multiple +6
Target Protein:
Coagulation factor X
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Valtorcitabine DB06187
small molecule | CAS: 380886-95-3

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vamifeport DB17692
small molecule | CAS: 2095668-10-1

Vamifeport is being investigated for the treatment of beta-thalassemia.

Kategori:
Heterocyclic Compounds, Fused-Ring
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vamikibart DB18896
biotech | CAS: 2744320-12-3

Vamikibart is under investigation in clinical trial NCT05642312 (A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vamorolone Approved DB15114
small molecule | CAS: 13209-41-1

Vamorolone is a novel and fully synthetic glucocorticoid developed by Santhera Pharmaceuticals. It is used to manage inflammation and immune dysregulation in patients with Duchenne muscular dystrophy (DMD), a neuromuscular disorder characterized by the insidi…

Kategori:
Adrenal Cortex HormonesAnti-Inflammatory AgentsCorticosteroids +20
Target Protein:
Glucocorticoid receptorMineralocorticoid receptor
Waktu ParuhThe terminal elimin…
Vol. DistribusiBased on population…
KlirensBased on population…
Genetik -
Vamotinib DB15396
small molecule | CAS: 1416241-23-0

Vamotinib (PF-114) is under investigation in clinical trial NCT02885766 (Study to Evaluate Tolerability, Safety, Pharmacokinetics and Preliminary Efficacy of PF-114 for Oral Administration in Adults With Ph+ Chronic Myeloid Leukemia, Which is Resistant to the…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vancomycin Approved DB00512
small molecule | CAS: 1404-90-6

Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to ristocetin that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear. As of January 29 2018, CutisPharma's Firvanq is the only FDA approved vanc…

Kategori:
Agents that produce neuromuscular block (indirect)Alimentary Tract and MetabolismAmino Acids, Peptides, and Proteins +17
Target Protein:
D-Ala-D-Ala moiety of NAM/NAG peptide subunits of peptidoglycan
Waktu ParuhHalf-life in normal…
Vol. DistribusiThe volume of distr…
KlirensThe mean plasma cle…
Genetik -
Vandetanib Approved DB05294
small molecule | CAS: 443913-73-3

Vandetanib is an oral once-daily kinase inhibitor of tumour angiogenesis and tumour cell proliferation with the potential for use in a broad range of tumour types. On April 6 2011, vandetanib was approved by the FDA to treat nonresectable, locally advanced…

Kategori:
Antineoplastic AgentsAntineoplastic and Immunomodulating AgentsBCRP/ABCG2 Inhibitors +15
Target Protein:
Vascular endothelial growth factor receptor 2Proto-oncogene tyrosine-protein kinase receptor RetEpidermal growth factor receptor +3
Waktu ParuhMedian half life of…
Vol. DistribusiVd of about 7450 L.
Klirens-
Genetik -
biotech | CAS: 2382896-00-4

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vanilla Approved DB10576
biotech

Vanilla allergenic extract is used in allergenic testing.

Kategori:
Cell-mediated ImmunityIncreased Histamine ReleaseNon-Standardized Food Allergenic Extract
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vanillic acid DB02130
small molecule | CAS: 121-34-6

A flavoring agent. It is the intermediate product in the two-step bioconversion of ferulic acid to vanillin. (J Biotechnol 1996;50(2-3):107-13).

Kategori:
Acids, CarbocyclicBenzene DerivativesBenzoates +5
Target Protein:
Chorismate pyruvate-lyase
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vanillyl butyl ether Approved DB11299
small molecule | CAS: 82654-98-6

Vanillyl butyl ether is an ether of monohydroxybenzoic acid. It is added to food products as a flavoring agent. It is also present in cosmetics and personal care products as a fragrance ingredient, oral care agent, hair conditioning agent, and warming or cool…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vaniprevir DB11929
small molecule | CAS: 923590-37-8

Vaniprevir has been used in trials studying the treatment and diagnostic of Hepatitis C, Chronic Hepatitis C, Hepatitis C, Chronic, Chronic Hepatitis C Infection, and Chronic Genotype 1 Hepatitis C Virus Infection.

Kategori:
AmidesAmino AcidsAmino Acids, Branched-Chain +9
Target Protein:
Gag-Pol polyprotein
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vanoxerine DB03701
small molecule | CAS: 67469-69-6

Vanoxerine is a highly selective dopamine transporter antagonist. It was synthesized in the late 1970s and developed as a potential treatment for depression.[A19824] Vanoxerine was later evaluated as a potential treatment for cocaine addiction due to its abil…

Kategori:
Antiarrhythmic agentsCytochrome P-450 CYP3A SubstratesCytochrome P-450 CYP3A4 Substrates +6
Target Protein:
Sodium-dependent dopamine transporterHERG human cardiac K+ channel
Waktu ParuhThe mean eliminatio…
Vol. DistribusiVanoxerine is capab…
KlirensAt 25, 75 and 125 m…
Genetik -
Vantictumab DB12956
biotech | CAS: 1345009-45-1

Vantictumab has been used in trials studying the treatment of Solid Tumors, Pancreatic Cancer, and Stage IV Pancreatic Cancer.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vanucizumab DB12317
biotech | CAS: 1448221-05-3

Vanucizumab has been used in trials studying the treatment of ColoRectal Cancer and Advanced/Metastatic Solid Tumors.

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +7
Target Protein:
Angiopoietin-2Vascular endothelial growth factor A, long form
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech | CAS: 886584-10-7

Vanutide cridificar has been investigated for the treatment of Alzheimer Disease.

Kategori:
Amino Acids, Peptides, and ProteinsProteinsRecombinant Proteins
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vapitadine DB05738
small molecule | CAS: 793655-64-8

Vapitadine is an antihistamine that Barrier Therapeutics is developing as a treatment for allergic reactions of the skin, such as those associated with hives and for the itch associated with atopic dermatitis. An advantage of vapitadine over other antihistami…

Target Protein:
Histamine H1 receptor
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vardenafil Approved DB00862
small molecule | CAS: 224785-90-4

Vardenafil is a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5) and an oral therapy for the treatment of erectile dysfunction.[L45563,L45568] During sexual stimulation, nitric oxide (NO) is released from n…

Kategori:
Cardiovascular AgentsCytochrome P-450 CYP2C19 InhibitorsCytochrome P-450 CYP2C19 Inhibitors (weak) +30
Target Protein:
cGMP-specific 3',5'-cyclic phosphodiesteraseRetinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gammaRetinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma
Waktu ParuhVardenafil and its …
Vol. DistribusiVardenafil has a st…
KlirensVardenafil has a to…
Genetik -
Varenicline Approved DB01273
small molecule | CAS: 249296-44-4

Varenicline is a prescription medication used to treat smoking addiction. This medication is the first approved nicotinic receptor partial agonist. Specifically, varenicline is a partial agonist of the alpha4/beta2 subtype of the nicotinic acetylcholine recep…

Kategori:
BenzazepinesCholinergic AgentsCholinergic Agonists +17
Target Protein:
Neuronal acetylcholine receptor subunit alpha-4Neuronal acetylcholine receptor subunit alpha-7Neuronal acetylcholine receptor subunit alpha-3 +2
Waktu ParuhThe elimination hal…
Vol. Distribusi-
Klirens-
Genetik -
small molecule | CAS: 172733-08-3

Varespladib methyl has been investigated for the treatment of Acute Coronary Syndrome. Studies showed that Varespladib methyl treatment resulted in significant positive changes on lipoproteins and inflammation.

Kategori:
Acids, AcyclicEnzyme InhibitorsFatty Acids +4
Target Protein:
Phospholipase A2, membrane associatedGroup 10 secretory phospholipase A2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Live attenuated zoster vaccine is available as two products: Zostavax for the prevention of shingles in immunocompetent people over the age of 50, and Varivax for the prevention of chickenpox in individuals 12 months of age and older. While the two vaccines c…

Kategori:
Actively Acquired ImmunityAntiinfectives for Systemic UseBiological Products +8
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Recombinant zoster vaccine, manufactured as the product Shingrix by GlaxoSmithKline, is an adjuvanted non-live recombinant vaccine indicated for prevention of shingles. First approved in October 2017 by the Food and Drug Administration, Shingrix is the prefer…

Kategori:
VaccinesVaricella Zoster Vaccines
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Varlitinib DB05944
small molecule | CAS: 845272-21-1

Varlitinib is an oral, selective, reversible, small molecule tyrosine kinase inhibitor of both ErbB-2 (Her-2/neu) and EGFR. Over-expression of ErbB-2 and EGFR receptors in tumors is predictive of poor prognosis in cancer patients. Varlitinib has shown signifi…

Kategori:
Heterocyclic Compounds, Fused-RingSulfur Compounds
Target Protein:
Epidermal growth factor receptorReceptor tyrosine-protein kinase erbB-2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Varoglutamstat DB18785
small molecule | CAS: 1276021-65-8

Deskripsi belum tersedia.

Target Protein:
Glutaminyl-peptide cyclotransferase
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vasopressin Approved DB00067
biotech | CAS: 11000-17-2

Vasopressin (arginine-vasopressin or antidiuretic hormone) is a nonapeptide primarily produced in the hypothalamus that exhibits diverse physiological functions related to diuresis, hemodynamic modulation, and behaviour.[A110, A111, A112, A113, A228008] Vasop…

Kategori:
Amino Acids, Peptides, and ProteinsAntidiuretic AgentsArginine Vasopressin +22
Target Protein:
Vasopressin V2 receptorVasopressin V1a receptorVasopressin V1b receptor +1
Waktu ParuhVasopressin adminis…
Vol. Distribusi-
KlirensVasopressin has a c…
Genetik -
Vatalanib DB04879
small molecule | CAS: 212141-54-3

Vatalanib (PTK787/ZK-222584) is a new oral antiangiogenic molecule that inhibits all known vascular endothelial growth factor receptors. Vatalanib is under investigation for the treatment of solid tumors.

Kategori:
Enzyme InhibitorsProtein Kinase InhibitorsPyridazines +1
Target Protein:
Epidermal growth factor receptorVascular endothelial growth factor receptor 3Vascular endothelial growth factor receptor 2 +1
Waktu ParuhApproximately 6 hou…
Vol. Distribusi-
Klirens-
Genetik -
Vatelizumab DB12346
biotech | CAS: 1238217-55-4

Vatelizumab has been used in trials studying the treatment of Ulcerative Colitis.

Kategori:
Amino Acids, Peptides, and ProteinsAntibodies, MonoclonalAntibodies, Monoclonal, Humanized +4
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Vayarin Approved DB09328
biotech

Vayarin is a prescription medical food for the clinical dietary management of certain lipid imbalances blamed to be associated with attention deficit hyperactivity disorder (ADHD) in children. Vayarin contains _Lipirinen_, a proprietary composition containing…

Kategori:
Cytochrome P-450 CYP2E1 InhibitorsCytochrome P-450 CYP2E1 Inhibitors (strength unknown)Cytochrome P-450 Enzyme Inhibitors
Waktu ParuhAbout 2h [L1507]
Vol. Distribusi-
KlirensMainly in the feces…
Genetik -
VB-201 DB15259
small molecule | CAS: 630112-41-3

VB-201 is under investigation in clinical trial NCT01001468 (Study to Assess VB-201 in Patients With Psoriasis).

Kategori:
AlcoholsCarbohydratesGlycerophosphates +10
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
VB-309 DB18539
small molecule | CAS: 2699021-75-3

Deskripsi belum tersedia.

Kategori:
Cannabinoids and similars
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
VB-310 DB18537
small molecule | CAS: 2699021-76-4

Deskripsi belum tersedia.

Kategori:
Cannabinoids and similars
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
VB-311 DB18540
small molecule | CAS: 2699021-77-5

Deskripsi belum tersedia.

Kategori:
Cannabinoids and similars
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
VB-312 DB18542
small molecule | CAS: 2699021-78-6

Deskripsi belum tersedia.

Kategori:
Cannabinoids and similars
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
VB-313 DB18541
small molecule | CAS: 2699021-79-7

Deskripsi belum tersedia.

Kategori:
Cannabinoids and similars
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
VB10.16 DB17512
biotech

VB10.16 is a novel therapeutic antigen-presenting cell-targeting DNA vaccine developed to treat HPV16-positive cancers. It is composed of three parts, one encodes the E6/E7 fusion protein of human papillomavirus (HPV) type 16 (HPV16), a dimerization entity, a…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
VB2-011 DB05411
biotech

VB2-011 is an antibody developed as an anti-cancer treatment. According to some preclinical studies, it has a potential to inhibit tumour growth in various cancers including lymphoma and melanoma. This drug includes the parent IgM (H11 IgM) and a recombinant …

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
VBI-1901 DB18476
biotech

VBI-1901 is a bivalent cytomeglaovirus gB/pp65 enveloped virus-like particles

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Menampilkan 12051–12100 dari 12560
Sebelumnya Halaman 242 / 252 Berikutnya